Evidence map›Paper›PMID 26859408›Full record

SynthesisPloS one2016

Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.

João Pedreira Duprat, Eduard René Brechtbülh, Bianca Costa de Sá, Mauro Enokihara, Jose Humberto Fregnani, Gilles Landman, Marcus Maia, Felice Riccardi, Francisco Alberto Belfort, Alberto Wainstein and 6 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

João Pedreira DupratAC Camargo Cancer Center, São Paulo, Brazil.
Eduard René BrechtbülhAC Camargo Cancer Center, São Paulo, Brazil.
Bianca Costa de SáAC Camargo Cancer Center, São Paulo, Brazil.
Mauro EnokiharaMedical School, São Paulo Federal University, São Paulo, Brazil.
Jose Humberto FregnaniBarretos Cancer Hospital, Barretos, Brazil.
Gilles LandmanMedical School, São Paulo Federal University, São Paulo, Brazil.
Marcus MaiaSanta Casa de Misericórdia, São Paulo, Brazil.
Felice RiccardiSanta Rita Hospital, Porto Alegre, Brazil.
Francisco Alberto BelfortSirio Libanês Hospital, Oswaldo Cruz Hospital, São José Hospital, São Paulo, Brazil.
Alberto WainsteinMinas Gerais School of Medicine, Belo Horizonte, Brazil.
Luciana F MoredoAC Camargo Cancer Center, São Paulo, Brazil.
Higino SteckMario Gatti Hospital, Campinas, Brazil.
Miguel BrandãoAMO Clinic, Salvador, Brazil.
Marcelo MorenoMedical School, Community University of Chapecó Region, Chapecó, Brazil.
Eduardo MirandaOncology Department, Pernambuco University, Recife, Brazil.
Ivan Dunshee de Oliveira SantosMedical School, São Paulo Federal University, São Paulo, Brazil.
AC Camargo Hospital · BRUniversidade Federal de São Paulo · BRCommunity University of Chapecó Region - Unochapecó · BRHospital de Câncer de Barretos · BRHospital Estadual Mário Covas · BRHospital São Paulo · BRIrmandade da Santa Casa de Misericórdia de São Paulo · BRSanta Casa Hospital · BRUniversidade de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study is to confirm the function of tumor-infiltrating lymphocytes (TILs) in sentinel lymph node (SLN) metastasis. MATERIALS AND

methodsThis retrospective study included 633 patients with invasive melanoma who underwent sentinel lymph node biopsy in 7 referral centers certified by the Brazilian Melanoma Group. Independent risk factors of sentinel node metastasis (SNL) were identified by multiple logistic regression.

resultsSLN metastasis was detected in 101 of 633 cases (16.1%) and in 93 of 428 patients (21.7%) when melanomas ≤ 1mm were excluded. By multiple logistic regression, the absence of TILs was as an independent risk factor of SLN metastasis (OR = 1.8; 95%CI: 1.1-3.0), in addition to Breslow index (greater than 2.00 mm), lymph vascular invasion, and presence of mitosis.

conclusionSLNB can identify patients who might benefit from immunotherapy, and the determination of predictors of SLNB positivity can help select the proper population for this type of therapy. The absence of TILs is a reproducible parameter that can predict SLNB positivity in melanoma patients, since this study was made with several centers with different dermatopathologists.

Indexed as

Cell CountDatabases, FactualBrazilFemaleHumansLymphatic MetastasisLymphocytes, Tumor-InfiltratingMaleMelanomaMiddle AgedPrognosisRetrospective Studies

Identifiers

PMID26859408
PMCPMC4747578
OpenAlexW2287080577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.